Exploring Mono and Bis‐gold(I)‐DTC Complexes Against Cancer and Leishmania
Chemistry – An Asian Journal · 2025
DOI: 10.1002/asia.202401553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Thaiz Cristina Soares Dos Santos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Síntese e Interações Bioinorgânicas (SibLab), Departmento de Química, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gold, Coordination Complexes, Leishmania. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Analytical Facility NEPS-DQ at Universidade Federal de Minas Gerais.
Abstract (Originalsprache)
Cancer is one of the main challenges of global public health and a leading cause of death, hindering the increase in life expectancy, and leishmaniasis occupies the second position in the number of deaths from parasitic diseases. Gold(I)‐based drugs are being studied for chemotherapy and have shown promising results, leading to the search for analogs with more favorable effect profiles. This work presents the synthesis and characterization of five new gold(I) complexes, [Au I DTCPPh 3 ] and [Au I 2 DTC(PPh 3 ) 2 ], using dithiocarbamate‐derived ligands and triphenylphosphine, with potential biological activity. The antiproliferative activity was investigated in breast tumor cell lines (MDA‐MB‐231 and 4T1) and a non‐tumor breast cell line (MCF‐10a), showing that complexation with gold enhances cytotoxic activity. The antileishmanial activity was investigated against intracellular amastigotes of Leishmania ( Viannia ) braziliensis , L . ( Leishmania ) amazonensis , and L . ( L .) infantum . All complexes demonstrated promising activity, especially the bis‐gold(I) complexes, which showed higher activity in the studied cell lines and Leishmania parasites. The results show the importance of the gold atom in these compounds, supporting the development of gold‐based compounds as prototypes for metallodrugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Síntese e Interações Bioinorgânicas (SibLab), Departmento de Química, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- RdM Lab - Biotechnology Applied to Pathogens Research Group (BAP), Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
- Laboratório de Química de Materiais Moleculares (LQMMol), Departmento de Química, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Heveline Silva
Förderung
- Analytical Facility NEPS-DQ at Universidade Federal de Minas Gerais
Zitieren
APA
Soares Dos Santos, T. C., Salvador Tessaro, P., de Andrade Querino, A. L., Rodrigues Neto, A. H., Evangelista, I. M. F., de Sousa, A. M., Nunes Rugani, J., Xerxes Coelho Oliveira, W., Lima do Monte-Neto, R., & Silva, H. (2025). Exploring Mono and Bis‐gold(I)‐DTC Complexes Against Cancer and Leishmania. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202401553
Vancouver
Soares Dos Santos TC, Salvador Tessaro P, de Andrade Querino AL, Rodrigues Neto AH, Evangelista IMF, de Sousa AM, et al. Exploring Mono and Bis‐gold(I)‐DTC Complexes Against Cancer and Leishmania. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202401553
BibTeX
@article{SoaresDosSantos2025,
author = {Soares Dos Santos, Thaiz Cristina and Salvador Tessaro, Patrícia and de Andrade Querino, Ana Luiza and Rodrigues Neto, Arthur Henrique and Evangelista, Igor Martins Felix and de Sousa, Alessandra Mara and Nunes Rugani, Jerônimo and Xerxes Coelho Oliveira, Willian and Lima do Monte-Neto, Rubens and Silva, Heveline},
title = {Exploring Mono and Bis‐gold(I)‐DTC Complexes Against Cancer and Leishmania},
journal = {Chemistry – An Asian Journal},
year = {2025},
doi = {10.1002/asia.202401553}
}
EUVIMED